Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Glen Laird

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Journal of Biopharmaceutical Statistics|May 31, 2021
Design and analysis of drop-the-losers studies using binary endpoints in the rare disease settingIna Jazić, Xiaoyan Liu, Glen Laird
Statistics in Medicine|April 30, 2013
Goodness-of-fit test for proportional subdistribution hazards modelBingqing Zhou, Jason Fine, Glen Laird
Substance Use & Misuse|August 12, 2003
Jail-based substance user treatment: an analysis of retentionChristopher P Krebs, Thomas Brady, Glen Laird
Journal of Biopharmaceutical Statistics|April 23, 2009
A Bayesian case study in oncology Phase I combination dose-finding using logistic regression with covariatesStuart Bailey, Beat Neuenschwander, Glen Laird, et al.
The American Journal on Addictions|February 10, 2004
Psychiatric comorbidity and not completing jail-based substance abuse treatmentThomas M Brady, Christopher P Krebs, Glen Laird
Clinical and Translational Science|March 2, 2021
Beyond exposure-response: A tutorial on statistical considerations in dose-ranging studiesGlen Laird, Lei Xu, Meng Liu, et al.
Statistics in Medicine|November 8, 2023
A Bayesian phase II proof-of-concept design for clinical trials with longitudinal endpointsWen Zhang, Glen Laird, Josh Chen, et al.
Journal of Biopharmaceutical Statistics|April 17, 2025
PS-SAM: propensity-score-integrated self-adapting mixture prior to dynamically and efficiently borrow information from historical dataYuansong Zhao, Peng Yang, Glen Laird, et al.
BMJ Open Respiratory Research|December 3, 2021
Burden of cystic fibrosis in children <12 years of age prior to the introduction of CFTR modulator therapiesKathryn Bresnick, Emilio Arteaga-Solis, Stefanie J Millar, et al.
Journal of Biopharmaceutical Statistics|March 29, 2023
A confirmatory basket design considering non-inferiority and superiority testingYaohua Zhang, Chenghao Chu, Robert A Beckman, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Journal of Biopharmaceutical Statistics|May 31, 2021
Design and analysis of drop-the-losers studies using binary endpoints in the rare disease settingIna Jazić, Xiaoyan Liu, Glen Laird
Statistics in Medicine|April 30, 2013
Goodness-of-fit test for proportional subdistribution hazards modelBingqing Zhou, Jason Fine, Glen Laird
Substance Use & Misuse|August 12, 2003
Jail-based substance user treatment: an analysis of retentionChristopher P Krebs, Thomas Brady, Glen Laird
Journal of Biopharmaceutical Statistics|April 23, 2009
A Bayesian case study in oncology Phase I combination dose-finding using logistic regression with covariatesStuart Bailey, Beat Neuenschwander, Glen Laird, et al.
The American Journal on Addictions|February 10, 2004
Psychiatric comorbidity and not completing jail-based substance abuse treatmentThomas M Brady, Christopher P Krebs, Glen Laird
Clinical and Translational Science|March 2, 2021
Beyond exposure-response: A tutorial on statistical considerations in dose-ranging studiesGlen Laird, Lei Xu, Meng Liu, et al.
Statistics in Medicine|November 8, 2023
A Bayesian phase II proof-of-concept design for clinical trials with longitudinal endpointsWen Zhang, Glen Laird, Josh Chen, et al.
Journal of Biopharmaceutical Statistics|April 17, 2025
PS-SAM: propensity-score-integrated self-adapting mixture prior to dynamically and efficiently borrow information from historical dataYuansong Zhao, Peng Yang, Glen Laird, et al.
BMJ Open Respiratory Research|December 3, 2021
Burden of cystic fibrosis in children <12 years of age prior to the introduction of CFTR modulator therapiesKathryn Bresnick, Emilio Arteaga-Solis, Stefanie J Millar, et al.
Journal of Biopharmaceutical Statistics|March 29, 2023
A confirmatory basket design considering non-inferiority and superiority testingYaohua Zhang, Chenghao Chu, Robert A Beckman, et al.
Pageof 2